RUTINOSCORBIN

This brand name is authorized in Lithuania, Poland

Active ingredients

The drug RUTINOSCORBIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Rutoside UNII RF4N03853G - RUTOSIDE TRIHYDRATE

Read about Rutoside

2 Vitamin C UNII PQ6CK8PD0R - ASCORBIC ACID

Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. Read about Vitamin C

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05CA51	Rutoside, combinations	C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents → C05CA Bioflavonoids
Discover more medicines within C05CA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007434, 1080812
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100059088